Maze Therapeutics, Inc.

SEC 4 · Filed

0001238403-26-000004Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jun 8, 2026

Grant, award or other acquisition by SPIEGELMAN DANIEL K

Security
Stock Option (Right to Buy)
Code
A
Shares
18,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-06-08",
  "direction": "A",
  "exercise_price": "23.58",
  "expiration": "2036-06-07",
  "footnotes": {
    "F1": "The option shall vest and be fully exercisable on the earlier of (i) the date of the issuer\u0027s 2027 annual stockholders meeting or (ii) June 8, 2027, subject to the reporting person\u0027s continued service to the issuer on the vesting date."
  },
  "owners": [
    {
      "cik": "0001238403",
      "name": "SPIEGELMAN DANIEL K",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "18000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (Right to Buy)",
  "shares": "18000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "18000"
}